ArifIDalviMDMBA

Neurology • Boynton Beach, FL

Movement Disorder, Neurodegenerative

Director, Comprehensive Movement Disorders Program Palm Beach Neuroscience Institute West Palm Beach, FL

Join to view full profile

Dr. Dalvi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dalvi's full profile

Already have an account?

Office
8756 Boynton Beach Blvd
Ste 2300
Boynton Beach, FL 33472
Phone+1 561-882-6214

Fax+1 561-882-6216

Education & Training

University of Cincinnati College of Medicine1997 - 1998
Columbia University Vagelos College of Physicians and Surgeons1996 - 1997
University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 1993 - 1996
Huron HospitalInternship, Internal Medicine, 1992 - 1993
Rural Medical College Pravara Institute of Medical SciencesClass of 1991

Certifications & Licensure

FL State Medical License 2014 - 2026
IL State Medical License 2002 - 2020
IN State Medical License 2013 - 2019
OH State Medical License 1997 - 2003
UT State Medical License 1995 - 1998
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Clinical Trials

Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa Start of enrollment: 2005 Mar 01
Completed
Phase 3
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease Start of enrollment: 2018 Feb 09
Active, not recruiting
Not Applicable
Azilect + Antidepressant Chart Review Start of enrollment: 2009 Jul 01
Completed
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis Start of enrollment: 2010 Jul 01
Completed
Phase 3
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease Start of enrollment: 2002 Mar 01
Terminated
Phase 2, Phase 3
A Longitudinal Observational Follow-up of the PRECEPT Study Cohort Start of enrollment: 2006 Aug 01
Unknown status
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease Start of enrollment: 2018 Sep 28
RECRUITING
NA
Join now to see all

Publications & Presentations

PubMed

36 citations
Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.
Vibhor Krishna, Paul S Fishman, Howard M Eisenberg, Michael Kaplitt, Gordon Baltuch
The New England Journal of Medicine. 2023-02-23
13 citations
Wilson's disease: etiology, diagnosis, and treatment
Arif Dalvi, Mahesh Padmanaban
Disease-a-Month. 2014-09-01
7 citations
Wilson’s disease: Neurological and psychiatric manifestations
Arif Dalvi
Disease-a-Month. 2014-09-01

Press Mentions

1 in 10 Seniors Has Dementia—Here’s Why That Matters Even if You’re in Your 20s, 30s, or 40sNovember 5th, 2022
This Surgery Is Giving Some Patients with Parkinson's Disease Their Lives BackMay 6th, 2021
APDA South Florida Chapter Presents “A Comprehensive Approach to Parkinson’s Disease” at Boca Raton MarriottDecember 25th, 2019
Join now to see all

Professional Memberships

American Academy of Neurology - AAN
Member